Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05BYO
|
||||
| Former ID |
DCL001203
|
||||
| Drug Name |
ISIS-SOD1
|
||||
| Drug Type |
Antisense drug
|
||||
| Indication | Amyotrophic lateral sclerosis [ICD9: 335.2; ICD10:G12.2] | Phase 1 | [551052] | ||
| Company |
ISIS Pharm
|
||||
| Target and Pathway | |||||
| Target(s) | mRNA of copper zinc superoxide dismutase 1 | Target Info | [551052] | ||
| BioCyc Pathway | Reactive oxygen species degradation | ||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| Pathway Interaction Database | Validated nuclear estrogen receptor alpha network | ||||
| FOXA1 transcription factor network | |||||
| PathWhiz Pathway | Degradation of Superoxides | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.